Farhat Afrin

JIS Institute of Advanced Studies and Research, JIS University, Kolkata, India

Dr. Farhat Afrin pursued a Ph.D. from the Indian Institute of Chemical Biology, India ,and postdoctoral studies from the National Institutes of Health, USA, and University of York, UK. An associate professor at JIS University with extensive experience in immunotherapeutics, nanomedicine, and vaccinology, she has earlier served Hamdard University, India, and Taibah University, Saudi Arabia. With over 62 publications in prestigious journals, h-index 34, and 2,643 citations per the Scopus database, Dr. Afrin has received numerous honors including the American Association of Immunologists Young Faculty Travel Grant, Commonwealth Academic Staff fellowship, Biotechnology Overseas Associateship, and International Association of Advanced Materials Scientist Award, to name a few. She has served as principal investigator on several research grants and is an editorial board member of numerous international journals and books.

Farhat Afrin

2books edited

1chapters authored

Latest work with IntechOpen by Farhat Afrin

Leishmania parasites plague the mammalian host causing high morbidity and mortality. The parasites persist in the hostile milieu, crippling its defensive arsenal. In the face of mounting resistance to an antiquated drug arsenal, new approaches are urgently desired to keep the infection at bay. Furthermore, to strengthen the leishmaniasis elimination drive, particular emphasis has to be laid on identification of new targets and vaccination strategies. This book gives a brief glimpse of the epidemiology of leishmaniasis, immune evasion, vaccination, and therapeutic modalities that may work by untangling the immunological cross-wires of pathogenic cross-talk. The Conventional treatment and its drawbacks, the prospects of phytotherapy and nanomedicines, are also discussed. The identification of drug targets with the aim of designing inhibitors is also exemplified.

Go to the book